PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

New substance effectively combats multi-resistant bacteria

2013-10-30
(Press-News.org) Contact information: Rasmus Jahnsen
rasmus.jahnsen@sund.ku.dk
45-26-27-88-04
University of Copenhagen
New substance effectively combats multi-resistant bacteria MULTI-RESISTANCE: In Europe alone, more than 25,000 people die each year from infections caused by multi-resistant bacteria. Researchers from University of Copenhagen have now developed and characterized a substance that quickly and effectively kills the virulent bacteria. The substance employs a multifunctional mechanism that reduces the risk of antibiotic resistance. The findings have recently been published in the scientific journal Chemistry & Biology.

Since WWII, antibiotics have made it possible to cure lethal bacterial infections. However, in recent years the efficacy of antibiotics has been drastically reduced due to increasing bacterial resistance. Today, bacteria resistant to nearly all known antibiotics are prevalent in many parts of the world.

"We have succeeded in preparing and characterizing a very stable substance that kills multi-resistant bacteria extremely quickly and effectively. The most interesting aspect is that the bacteria are attacked using a multifunctional mechanism that drastically reduces the risk of resistance development compared with traditional antibiotics," says Rasmus Jahnsen.

Jahnsen conducted the research into the development of substances against multi-resistant bacteria at the Department of Drug Design and Pharmacology, University of Copenhagen.

The recently developed substance is called HDM-4, which stands for Host Defence Peptidomimetic 4. The findings are the result of collaboration between University of Copenhagen and the University of British Columbia in Canada.

Boosts the innate immune response

For a number of years, a group of researchers led by Associate Professor Henrik Franzyk at the Faculty of Health and Medical Sciences have worked on the optimization of a unique class of antibacterial substances. All plants, animals and humans produce the important antimicrobial peptides that form part of the innate immune system – the body's first line of defence against bacterial attack.

"The killing mechanism involves destabilising the bacterial membrane and binding onto the bacteria's DNA, which in both cases results in the death of the bacteria. We have also shown that the substance can activate the human body's own immune cells, strengthening its defence against bacteria during infection," says Rasmus Jahnsen.

Pharmaceutical industry lacks interest in antibiotics

The researchers have tested the new substance on bacteria-infected tissue and the results show that it possesses several characteristics that make it highly attractive in connection with the possible development of new antibiotics.

"It's the first step to developing a new drug. We hope that in collaboration with partners we can conduct a series of tests in the near future to show that the substance can actually combat an infection in a mammal. If we achieve the same results in animals, we will have a potential sensation on our hands," adds Rasmus Jahnsen.

Jahnsen believes the pharmaceutical industry needs to become more actively involved.

"Only a tiny fraction of the pharmaceutical research is devoted to development of new antibiotics — partly because research into cancer and chronic diseases such as diabetes and cardiovascular diseases are seen as better long-term investments. This leaves us in the extremely unfortunate situation where infectious diseases once again pose extremely serious threats to human health as the efficacy of medical drugs continues to be undermined by bacterial resistance. It is therefore important to conduct more research into new antibiotics," concludes Rasmus Jahnsen.

### Fact box: The research is the result of a collaboration between University of Copenhagen and the University of British Columbia (UBC) in Canada. Initially, the researchers at the Department of Drug Design and Pharmacology (DDP), University of Copenhagen, focused on identifying the ideal chemical structure together with an effective method for its preparation. They subsequently tested and characterised the substance at the Centre for Microbial Disease and Immunity Research (UBC), where Rasmus Jahnsen spent six months as a guest researcher in connection with his PhD project entitled "Peptidomimetics as novel antibiotics" that has been carried out in the Natural Products Research (NPR) Group at DDP (Faculty of Health and Medical Sciences) with Associate Professor Henrik Franzyk as main supervisor and Professor Niels Frimodt-Møller (SSI/Hvidovre Hospital) as co-supervisor. The PhD project constitutes a part of the strategic research centre DanCARD (Danish Centre for Antibiotic Research and Development).


ELSE PRESS RELEASES FROM THIS DATE:

Moral in the morning, but dishonest in the afternoon

2013-10-30
Moral in the morning, but dishonest in the afternoon Our ability to exhibit self-control to avoid cheating or lying is significantly reduced over the course of a day, making us more likely to be dishonest in the afternoon than in the ...

Institute explores intimate partner violence across generations

2013-10-30
Institute explores intimate partner violence across generations HUNTSVILLE, TX (10/30/13) -- Most parents who experienced intimate partner violence had children that grew to face violence in their own adult relationships, according to a study published by the Crime ...

How fat could help solve part of the diabetes problem

2013-10-29
How fat could help solve part of the diabetes problem The pancreas is a large organ that wraps around our gut, and produces the exact amount of insulin our bodies need when we eat – except when we start to develop diabetes, and insulin production ...

Did brain tumor stem cells originate from malignant neural stem cells?

2013-10-29
Did brain tumor stem cells originate from malignant neural stem cells? Although it is believed that glioma is derived from brain tumor stem cells, the source and molecular signal pathways of these cells are still unclear. The potential of neural stem cells to ...

Association between glioma susceptibility and XRCC1 Arg399Gln polymorphism

2013-10-29
Association between glioma susceptibility and XRCC1 Arg399Gln polymorphism DNA damage is an important mechanism of glioma. X-ray cross-complementing group 1 (XRCC1) is a DNA repair gene that participates in the base excision repair pathway. To date, many studies ...

A new DNA vaccine induces a Th2 immune response in Alzheimer's disease mice

2013-10-29
A new DNA vaccine induces a Th2 immune response in Alzheimer's disease mice Amyloid-beta (Aβ) active immunization in Alzheimer's disease can increase the rate of Aβ clearance, and delay cognitive dysfunction, but it is easy to induce meningoencephalitis, ...

New drug to help common bowel disease

2013-10-29
New drug to help common bowel disease An international team led by University of Adelaide researchers has identified the mechanism of pain relief of a new drug for treating Irritable Bowel Syndrome with Constipation (IBS-C), based on nonclinical ...

Human immune system shapes skin microbiome

2013-10-29
Human immune system shapes skin microbiome October 29, 2013 -- Our skin plays host to millions of beneficial and potentially disease-causing microorganisms; however, whether our immune system influences these microbial communities to prevent disease is ...

Pregnant rats exposed to obesity hormone lose birth's protective effect on breast cancer

2013-10-29
Pregnant rats exposed to obesity hormone lose birth's protective effect on breast cancer WASHINGTON — Like humans, young rats that give birth have a reduced risk of breast cancer later in life. But a new study shows that this protective effect in animals is negated ...

A potential new class of fast-acting antidepressant

2013-10-29
A potential new class of fast-acting antidepressant More than 1 in 10 Americans take antidepressants, but these medications can take weeks—and for some patients, months—before they begin to alleviate symptoms. Now, scientists from the University ...

LAST 30 PRESS RELEASES:

Computational biology paves the way for new ALS tests

Study offers new hope for babies born with opioid withdrawal syndrome

UT, Volkswagen Group of America celebrate research partnership

New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll

Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes

University of Cincinnati Cancer Center presents research at AACR 2025

Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025

AACR: Researchers share promising results from MD Anderson clinical trials

New research explains why our waistlines expand in middle age

Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker

Chips off the old block

Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia

Cutting the complexity from digital carpentry

Lung immune cell type “quietly” controls inflammation in COVID-19

Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity

State and sociodemographic trends in US cigarette smoking with future projections

Young adults drive historic decline in smoking

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

Chimpanzee stem cells offer new insights into early embryonic development

This injected protein-like polymer helps tissues heal after a heart attack

FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology

In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity

Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects

A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions

AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate

Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative

Structure dictates effectiveness, safety in nanomedicine

Mission accomplished for the “T2T” Hong Kong Bauhinia Genome Project

Study identifies how malaria can lead to childhood cancer

An earth-abundant mineral for sustainable spintronics

[Press-News.org] New substance effectively combats multi-resistant bacteria